Atom Investors’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$611K Buy
4,863
+1,048
+27% +$132K 0.05% 325
2025
Q1
$422K Buy
+3,815
New +$422K 0.05% 316
2019
Q1
Sell
-40,511
Closed -$2.89M 646
2018
Q4
$2.89M Buy
+40,511
New +$2.89M 0.28% 74